To characterize somatic alterations in colorectal carcinoma, we conducted a genome-scale analysis of 276 samples, analysing exome sequence, DNA copy number, promoter methylation and messenger RNA and microRNA expression. A subset of these samples (97) underwent low-depth-of-coverage whole-genome sequencing. In total, 16% of colorectal carcinomas were found to be hypermutated: three-quarters of these had the expected high microsatellite instability, usually with hypermethylation and MLH1 silencing, and one-quarter had somatic mismatch-repair gene and polymerase µ (POLE) mutations. Excluding the hypermutated cancers, colon and rectum cancers were found to have considerably similar patterns of genomic alteration. Twenty-four genes were signifi...
Colorectal cancer (CRC) is a biologically heterogeneous disease. To characterize its mutational prof...
Introduction : Despite improved screening programs and modern treatments, colorectal cancer (CRC) st...
Colorectal cancer (CRC) is a biologically heterogeneous disease. To characterize its mutational prof...
To characterize somatic alterations in colorectal carcinoma, we conducted a genome-scale analysis of...
To characterize somatic alterations in colorectal carcinoma (CRC), we conducted genome-scale analysi...
To characterize somatic alterations in colorectal carcinoma (CRC), we conducted genome-scale analysi...
To characterize somatic alterations in colorectal carcinoma, we conducted a genome-scale analysis of...
Colorectal cancer (CRC) is an aging related disease with 72% of newly diagnosed cases aged 65 years ...
Human colorectal cancer cell lines are used widely to investigate tumor biology, experimental therap...
Human colorectal cancer cell lines are used widely to investigate tumor biology, experimental therap...
Background: Colorectal cancer (CRC) is with approximately 1 million cases the third most common canc...
Introduction : Despite improved screening programs and modern treatments, colorectal cancer (CRC) st...
Colorectal cancer (CRC) is a biologically heterogeneous disease. To characterize its mutational prof...
Colorectal cancer (CRC) is a biologically heterogeneous disease. To characterize its mutational prof...
Inherited factors account for around one third of all colorectal cancers (CRCs) and include rare hig...
Colorectal cancer (CRC) is a biologically heterogeneous disease. To characterize its mutational prof...
Introduction : Despite improved screening programs and modern treatments, colorectal cancer (CRC) st...
Colorectal cancer (CRC) is a biologically heterogeneous disease. To characterize its mutational prof...
To characterize somatic alterations in colorectal carcinoma, we conducted a genome-scale analysis of...
To characterize somatic alterations in colorectal carcinoma (CRC), we conducted genome-scale analysi...
To characterize somatic alterations in colorectal carcinoma (CRC), we conducted genome-scale analysi...
To characterize somatic alterations in colorectal carcinoma, we conducted a genome-scale analysis of...
Colorectal cancer (CRC) is an aging related disease with 72% of newly diagnosed cases aged 65 years ...
Human colorectal cancer cell lines are used widely to investigate tumor biology, experimental therap...
Human colorectal cancer cell lines are used widely to investigate tumor biology, experimental therap...
Background: Colorectal cancer (CRC) is with approximately 1 million cases the third most common canc...
Introduction : Despite improved screening programs and modern treatments, colorectal cancer (CRC) st...
Colorectal cancer (CRC) is a biologically heterogeneous disease. To characterize its mutational prof...
Colorectal cancer (CRC) is a biologically heterogeneous disease. To characterize its mutational prof...
Inherited factors account for around one third of all colorectal cancers (CRCs) and include rare hig...
Colorectal cancer (CRC) is a biologically heterogeneous disease. To characterize its mutational prof...
Introduction : Despite improved screening programs and modern treatments, colorectal cancer (CRC) st...
Colorectal cancer (CRC) is a biologically heterogeneous disease. To characterize its mutational prof...